MAPT and Alzheimer disease: Though this tracer not only reveals a roughly 30–50-fold higher tau-specific binding affinity compared to beta-amyloid plaques, its retention in the medial temporal region, the precuneus, and the frontal cortex, shows good correlation to the cognitive decline in AD patients [24,25].